期刊文献+

妊娠期肝内胆汁淤积症两种治疗方法比较 被引量:3

原文传递
导出
摘要 目的:评估治疗妊娠期肝内胆汁淤积症(ICP)的两种方案:腺苷蛋氨酸(思美泰)联合多烯磷脂酰胆碱(易善复)对比熊去氧胆酸联合考来烯胺(消胆胺)的临床疗效。方法:将100例ICP患者随机分为两组,易善复组56例,联合应用易善复和思美泰治疗;消胆胺组44例,联合应用消胆胺和熊去氧胆酸治疗。疗程均为2周。追踪治疗前后的血胆汁酸及肝转氨酶水平,及其妊娠结局。比较两种治疗方案的效果。结果:两组患者治疗后的血胆汁酸(TBA)及肝转氨酶(ALT和AST)水平均低于治疗前,易善复组改善TBA、ALT和AST的疗效显著优于消胆胺组,差异具有统计学意义(P<0.05);易善复组妊娠早产率低、新生儿窒息率低、产后出血量少。结论:思美泰与易善复联合治疗比熊去氧胆酸联合消胆胺治疗可以明显改善妊娠期肝内胆汁淤积症的生化指标和妊娠结局,提高围生儿的生存质量。
出处 《中国妇幼保健》 CAS 北大核心 2011年第6期947-948,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献9

  • 1Nicholls AA. Cholestasis of pregnancy: a review of the evidence [J] . Perinat Neonatal Nuts, 2005, 19 (3): 215. 被引量:1
  • 2乐杰..妇产科学[M].北京:人民卫生出版社,2008:4图版.
  • 3Rihalta J, Reyes H, Gonazfez MC et al. S - adenosyl - L - rnethionine in the treatment of patients with intrahepatic cholestsis of pregnancy: a randomized double - blind, placebo controlled study with negative results [J].Hepatology, 1991, 13 (1): 1081. 被引量:1
  • 4Paumgartner G, Pusl T. Medical treatment of cholestatic liver disease[J].ClinLiverDis, 2008, 12 (1): 531. 被引量:1
  • 5Sentilhes L, Verspyck E, Roman H et al. lntrahepatic cholestasis of pregnancy and bile acid levels[J] . Hepatology, 2005, 42 (3) : 737. 被引量:1
  • 6董旻岳.妊娠期肝内胆汁淤积症孕妇肝功能指标、胆汁酸的变化及与围产儿预后的关系[J].实用妇产科杂志,2002,18(1):7-8. 被引量:102
  • 7Germain AM, Carvajal JA, Glasinoric JC. Intrahepatic cholestasis of pregnancy: an intriguing pregnancy -specific disorder [J] . J Soc Gynecol Investig, 2002, 9 (1) : 10. 被引量:1
  • 8Kondracklene J, Beuers U, Kupcinakas L Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy [J] . Gastroenterology. 2005, 129 (3): 8941. 被引量:1
  • 9李骏,蒋佩茹.妊娠期肝内胆汁淤积症的研究现状[J].肝脏,2009,14(1):77-79. 被引量:9

二级参考文献20

  • 1徐慧,曹来英,魏敏,张尉,曾洁.妊娠肝内胆汁淤积症孕妇肝胆B超特点及临床意义[J].中国优生与遗传杂志,2005,13(11):75-77. 被引量:1
  • 2王浛知,金丽,董旻岳,王正平.妊娠期肝内胆汁淤积症细胞免疫与辅助T细胞亚群功能的研究[J].中国妇幼保健,2007,22(9):1156-1158. 被引量:1
  • 3Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatie cholestasis of pregnancy. Ann Med, 2000, 32: 94- 106. 被引量:1
  • 4Yamamoto Y, Moore R, Hess HA, et al. Estrogen Receptor αlpha mediates 17 αlpha-ethynylestradiol causing hepatotoxicity. J Biol Chem, 2006, 281 :16625-16631. 被引量:1
  • 5Milkiewicz P, Elias E, Williamson C, et al. Obstetric cholestatsis. BMJ, 2002, 324: 123-124. 被引量:1
  • 6Eloranta ML, Heinonen S, Mononen T, et al. Risk of obstetric cholestasis in sisters of index patients. Clin Genet, 2001, 60:422-445. 被引量:1
  • 7Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump ( ABCBll ) and multidrug resistance pglycoprotein 3 (AB2CB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmaeogenetics, 2004, 14 : 91-102. 被引量:1
  • 8Dixon PH, Weerasekera N, Linton KJ, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Gen, 2000, 9: 1209-1217. 被引量:1
  • 9Kauppila A, Korpela H, Makila UM, et al. Low serum selenium concentration and glutathione peroxidaseactivity in intrahepatic cholestasis of pregnancy. Br Med J, 1987, 294:150-152. 被引量:1
  • 10Dann AT, Kenyon AP, Wierzbicki AS, et al. Plasma lipid profiles of women with intraphepatic cholestasis of pregnancy. Obstet Gynecol, 2006,107 : 106-114. 被引量:1

共引文献109

同被引文献38

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部